IDEX Biometrics ASA
IDXAF
$0.20
$0.10100.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -78.96% | -72.04% | -95.05% | -93.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -78.96% | -72.04% | -95.05% | -93.68% |
| Cost of Revenue | -71.43% | -75.54% | -63.71% | 6.27% | -96.18% |
| Gross Profit | -125.00% | -84.21% | -86.67% | -84.15% | -85.25% |
| SG&A Expenses | -72.28% | -73.17% | -71.77% | -46.27% | -48.16% |
| Depreciation & Amortization | 135.48% | -87.27% | -63.87% | 179.17% | -195.88% |
| Other Operating Expenses | -18.95% | -7.78% | -20.81% | 9.43% | -44.51% |
| Total Operating Expenses | -51.80% | -50.85% | -49.19% | 2.64% | -46.74% |
| Operating Income | 51.09% | 49.04% | 47.77% | -11.58% | 40.15% |
| Income Before Tax | -172.94% | 68.31% | 23.58% | 21.64% | 119.33% |
| Income Tax Expenses | -- | -2,250.00% | -- | -913.33% | -- |
| Earnings from Continuing Operations | -172.94% | 68.96% | 23.54% | 24.36% | 119.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -172.94% | 68.96% | 23.54% | 24.36% | 119.35% |
| EBIT | 51.09% | 49.04% | 47.77% | -11.58% | 40.15% |
| EBITDA | 51.60% | 40.41% | 46.58% | -12.71% | 40.12% |
| EPS Basic | -105.44% | 96.97% | 74.30% | 60.01% | 116.46% |
| Normalized Basic EPS | -105.42% | 96.91% | 98.93% | 58.57% | 116.45% |
| EPS Diluted | -105.49% | 96.94% | 75.09% | 60.01% | 114.33% |
| Normalized Diluted EPS | -105.43% | 96.91% | 98.93% | 58.40% | 116.51% |
| Average Basic Shares Outstanding | 1,244.44% | 924.96% | 197.45% | 89.17% | 17.54% |
| Average Diluted Shares Outstanding | 1,240.76% | 924.96% | 197.45% | 88.36% | 17.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |